Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors

Journal of Clinical Medicine
Mauro CivesJonathan R Strosberg

Abstract

Treatment options for neuroendocrine tumors (NETs) and carcinomas (NECs) are expanding. Early-phase studies have shown preliminary evidence of the antitumor activity of alpha-emitting peptide receptor radionuclide therapy (PRRT), and novel radiopeptides incorporating somatostatin receptor antagonists (rather than agonists) have been developed. Several tyrosine kinase inhibitors (TKIs) with antiangiogenic potential have been evaluated in patients with NETs, including lenvatinib, axitinib, cabozantinib and pazopanib. Recently, two phase 3 clinical trials have demonstrated the efficacy and safety of surufatinib, an inhibitor of vascular endothelial growth factor receptor (VEGFR)-1, -2, -3, fibroblast growth factor receptor (FGFR)-1 and colony stimulating factor-1 receptor (CSF-1R), in patients with pancreatic and extra-pancreatic NETs. Multiple clinical trials of combination immunotherapy have been recently completed, but interpretation of the results is hampered by small samples sizes and discordant outcomes. This review summarizes recent data on emerging treatments for neuroendocrine neoplasms.

References

Feb 14, 2007·Cell Cycle·Helen DodsonCiaran G Morrison
Feb 11, 2011·The New England Journal of Medicine·Eric RaymondPhilippe Ruszniewski
Feb 11, 2011·The New England Journal of Medicine·James C YaoUNKNOWN RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group
Jul 12, 2014·The New England Journal of Medicine·Martyn E CaplinUNKNOWN CLARINET Investigators
Jun 13, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E GrandeR García-Carbonero
Dec 26, 2015·Lancet·James C YaoUNKNOWN RAD001 in Advanced Neuroendocrine Tumours, Fourth Trial (RADIANT-4) Study Group
Apr 16, 2016·Endocrine-related Cancer·J R StrosbergE K Bergsland
Jan 12, 2017·The New England Journal of Medicine·Jonathan StrosbergUNKNOWN NETTER-1 Trial Investigators
Feb 22, 2017·Current Oncology Reports·Mauro Cives, Jonathan Strosberg
Apr 22, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tessa BrabanderDik J Kwekkeboom
May 10, 2017·Environmental and Molecular Mutagenesis·Nimrat Chatterjee, Graham C Walker
Apr 1, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Lisa Bodei, Wolfgang A Weber
Oct 9, 2018·CA: a Cancer Journal for Clinicians·Mauro Cives, Jonathan R Strosberg
Jan 31, 2019·Neuroendocrinology·Mauro CivesFranco Silvestris
Feb 9, 2019·Journal of Medicinal Chemistry·Brian H WhiteMark T Bilodeau
Mar 6, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jianming XuWeiguo Su
Mar 31, 2019·Molecular Cancer Therapeutics·Tania A Rozgaja StallonsJulien J Torgue
Aug 24, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Diane Reidy-LagunesWolfgang A Weber
Sep 1, 2019·Seminars in Nuclear Medicine·Jingjing ZhangRichard P Baum
Jan 24, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sandip P PatelRazelle Kurzrock
Jan 26, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jonathan StrosbergJulien Hadoux
May 25, 2020·Current Treatment Options in Oncology·Donna D'SouzaShamar Young
Jun 14, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Oliver KleinJonathan Cebon
Jun 27, 2020·Endocrine-related Cancer·Tim J TakkenkampAnnemiek M E Walenkamp
Jun 28, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kyriakos P PapadopoulosSai-Hong Ignatius Ou

❮ Previous
Next ❯

Citations

Jan 16, 2021·Journal of Clinical Medicine·Francesco Panzuto
Apr 15, 2021·Reviews in Endocrine & Metabolic Disorders·Manuela AlbertelliDiego Ferone
Apr 28, 2021·Seminars in Cancer Biology·Grigoris EffraimidisUlla Feldt-Rasmussen
Jun 19, 2021·Expert Review of Anticancer Therapy·Xiuhua LuZhongguang Chen

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT03466216
NCT01744249
NCT03375320
NCT03411915
NCT02749331

Software Mentioned

AdVince
CABINET
SANET
irRECIST
AXINET
PAZONET

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Therapeutics
Emilio BajettaMichele Del Vecchio
Visceral Medicine
Sze Ting LeeRichard P Baum
Endocrinology and Metabolism Clinics of North America
Sandrine FaivreEric Raymond
Endocrine-related Cancer
Mintallah HaiderJonathan R Strosberg
© 2021 Meta ULC. All rights reserved